Login / Signup

Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature.

Jorge Magdaleno TapialCristian Alejandro Valenzuela-OñateMarta García-Legaz-MartínezÁlvaro Martínez DomenechAmparo Pérez-Ferriols
Published in: The Australasian journal of dermatology (2019)
Dupilumab, a biologic drug approved for the treatment of moderate-to-severe atopic dermatitis, has been associated with resolution or improvement in pre-existing alopecia areata. We report a case of significant improvement of AA after Dupilumab-onset treatment for atopic dermatitis and review the literature.
Keyphrases
  • atopic dermatitis
  • systematic review
  • rheumatoid arthritis
  • early onset
  • drug induced
  • high intensity
  • single molecule
  • adverse drug
  • drug administration